CLS Holdings, Inc., Chairman and CEO Jeff Binder Joins Uptick Newswire’s “Stock Day” with Everett Jolly

PHOENIX, Feb. 20, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB:CLSH) (CLS) ("the Company"), today announced an interview with Everett Jolly on Uptick Newswire’s “Stock Day” podcast.

CLS Holdings is a science-based cannabis company, which intends to diversify geographically and through strategic acquisitions.  The company recently received its first patent allowance and intends to license its proprietary, patented conversion and extraction process to major growers and extractors globally. Additionally, the company is in the process of developing a complete line of branded products.

CLS will obtain four new licenses in Nevada upon the completion of its acquisition of Alternative Solutions (dba Oasis Cannabis).

“CLS Holdings is seeking to be one of the dominant players in the cannabis industry in the next five years,” said Jolly.  “CLS Co-Founder Ray Keller, a nuclear chemist, has contributed his cannabis related IP to CLS. It is believed that this expertise will provide CLS with a distinct competitive advantage in the extraction and conversion of the cannabis plant."

“When the acquisition of Oasis Cannabis is complete – which is expected to occur in the second quarter of 2018 – based upon the Oasis projections, we believe we can achieve 2018 revenue of $12 million and 2019 revenue of $23 million,” said Binder.  “The acquisition provides a platform for us to deploy our corporate marketing expertise and a facility to build out our proprietary conversion and extraction lab. It is our goal to produce consistent high quality product at a fair price.”

To listen to the full interview please click here to the following link: https://upticknewswire.com/featured-interview-ceo-jeffrey-binder-of-cls-holdings-usa-inc-otcqb-clsh/

About CLS Holdings USA
CLS Holdings USA, Inc. (OTCQB:CLSH) plans to become a diversified cannabis company and is expanding its corporate strategy to becoming a fully licensed integrated cannabis producer and retailer in Nevada and other western states. Its strategy and business model will be similar to Canopy Growth, Aurora Cannabis and GB Sciences.

CLS stands for "Cannabis Life Sciences," in recognition of the Company's patent pending proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. CLS has recently received a Notice of Allowance from the U.S. Patent Office for this methodology.  The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.

About Uptick Newswire and the “Stock Day Podcast”
Uptick Newswire is a private company reaching out to the masses keeping investors and shareholders up to date on company news and bringing transparency to the undervalued, undersold, micro-cap stocks of the market and is the sole producer of the Uptick Network “Stock Day” Podcast. The Uptick Network “Stock Day” Podcast is an extension of Uptick.

Follow us and keep an eye on Uptick’s YouTube, Twitter, and Facebook​ for additional radio and video shows produced by Uptick! ​https://www.youtube.com/watch?v=kU5SVLp4org

Investors Hangout is a proud sponsor of Stock Day and Uptick Newswire encourages listeners to visit CLS Holdings USA’s message board on: https://investorshangout.com/CLS-Holdings-USA-Inc-CLSH-92115/

Disclaimer
CLS has executed a definitive agreement to acquire the Oasis Cannabis companies (Alternative Solutions, LLC).  The closing of the transaction is subject to the satisfaction of a number of conditions including our ability to raise cash, and as a result, there can be no assurance that we will be able to close the Oasis Acquisition. See CLS Holdings USA’s filings with the SEC for additional details.
Twitter: @CLSHusa 

Forward Looking Statements
This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. These forward-looking statements include, but are not limited to, statements relating to whether certain transactions will be completed, the terms of such transactions, the descriptions of the companies and the business that any potential target companies could bring to CLS Holdings. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "should," "intends," "expects," "plans," "goals," "projects," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. We cannot guarantee future results, levels of activity or performance and we cannot guaranty that the proposed transactions described in this press release will occur. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events.

CLS Holdings USA has entered into a definitive agreement to acquire Oasis Cannabis, which is expected to close in the second quarter of 2018. See CLS Holdings USA filings with the SEC for additional details.

Contact:
Chairman and CEO Jeff Binder
jeff@clsholdingsinc.com
888-438-9132

Investor Relations
Hayden IR
clsh@haydenir.com
917-658-7878

Source: Uptick Newswire

Released February 20, 2018